|
Originally published In Press as doi:10.1074/jbc.M611393200 on March 15, 2007
J. Biol. Chem., Vol. 282, Issue 19, 14328-14336, May 11, 2007
MicroRNA-21 Targets the Tumor Suppressor Gene Tropomyosin 1 (TPM1)*
Shuomin Zhu,
Min-Liang Si,
Hailong Wu, and
Yin-Yuan Mo1
From the
Department of Medical Microbiology, Immunology, and Cell Biology, Southern Illinois University School of Medicine, Springfield, Illinois 62794
MicroRNAs are small noncoding RNA molecules that control expression of target genes. Our previous studies show that mir-21 is overexpressed in tumor tissues compared with the matched normal tissues. Moreover, suppression of mir-21 by antisense oligonucleotides inhibits tumor cell growth both in vitro and in vivo. However, it remains largely unclear as to how mir-21 affects tumor growth, because our understanding of mir-21 targets is limited. In this study, we performed two-dimensional differentiation in-gel electrophoresis of tumors treated with anti-mir-21 and identified the tumor suppressor tropomyosin 1 (TPM1) as a potential mir-21 target. In agreement with this, there is a putative mir-21 binding site at the 3'-untranslated region (3'-UTR) of TPM1 variants V1 and V5. Thus, we cloned the 3'-UTR of TPM1 into a luciferase reporter and found that although mir-21 down-regulated the luciferase activity, anti-mir-21 up-regulated it. Moreover, deletion of the mir-21 binding site abolished the effect of mir-21 on the luciferase activity, suggesting that this mir-21 binding site is critical. Western blot with the cloned TPM1-V1 plus the 3'-UTR indicated that TPM1 protein level was also regulated by mir-21, whereas real-time quantitative reverse transcription-PCR revealed no difference at the mRNA level, suggesting translational regulation. Finally, overexpression of TPM1 in breast cancer MCF-7 cells suppressed anchorage-independent growth. Thus, down-regulation of TPM1 by mir-21 may explain, at least in part, why suppression of mir-21 can inhibit tumor growth, further supporting the notion that mir-21 functions as an oncogene.
Received for publication, December 12, 2006
, and in revised form, March 15, 2007.
* This work was supported by Grants CA102630 from the National Institutes of Health and BC045418 and BC052294 from the United States Department of Defense. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence should be addressed: Dept. of Medical Microbiology, Immunology, and Cell Biology, Southern Illinois University School of Medicine, 801 N. Rutledge, P. O. Box 19626, Springfield, IL 62794. Tel.: 217-545-8508; E-mail: ymo{at}siumed.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. Sotiropoulou, G. Pampalakis, E. Lianidou, and Z. Mourelatos
Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell
RNA,
August 1, 2009;
15(8):
1443 - 1461.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T.-H. Huang, F. Wu, G. B. Loeb, R. Hsu, A. Heidersbach, A. Brincat, D. Horiuchi, R. J. Lebbink, Y.-Y. Mo, A. Goga, et al.
Up-regulation of miR-21 by HER2/neu Signaling Promotes Cell Invasion
J. Biol. Chem.,
July 3, 2009;
284(27):
18515 - 18524.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Qin, B. Zhao, Y. Shi, C. Yao, L. Jin, and Y. Jin
BMPRII is a direct target of miR-21
Acta Biochim Biophys Sin,
July 1, 2009;
41(7):
618 - 623.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Li, H. Huang, L. Sun, M. Yang, C. Pan, W. Chen, D. Wu, Z. Lin, C. Zeng, Y. Yao, et al.
MiR-21 Indicates Poor Prognosis in Tongue Squamous Cell Carcinomas as an Apoptosis Inhibitor
Clin. Cancer Res.,
June 15, 2009;
15(12):
3998 - 4008.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Yamamichi, R. Shimomura, K.-i. Inada, K. Sakurai, T. Haraguchi, Y. Ozaki, S. Fujita, T. Mizutani, C. Furukawa, M. Fujishiro, et al.
Locked Nucleic Acid In situ Hybridization Analysis of miR-21 Expression during Colorectal Cancer Development
Clin. Cancer Res.,
June 15, 2009;
15(12):
4009 - 4016.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Dyrskjot, M. S. Ostenfeld, J. B. Bramsen, A. N. Silahtaroglu, P. Lamy, R. Ramanathan, N. Fristrup, J. L. Jensen, C. L. Andersen, K. Zieger, et al.
Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro
Cancer Res.,
June 1, 2009;
69(11):
4851 - 4860.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. T. Huse, C. Brennan, D. Hambardzumyan, B. Wee, J. Pena, S. H. Rouhanifard, C. Sohn-Lee, C. le Sage, R. Agami, T. Tuschl, et al.
The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo
Genes & Dev.,
June 1, 2009;
23(11):
1327 - 1337.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Velu, A. M. Baktula, and H. L. Grimes
Gfi1 regulates miR-21 and miR-196b to control myelopoiesis
Blood,
May 7, 2009;
113(19):
4720 - 4728.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S M Khoshnaw, A R Green, D G Powe, and I O Ellis
MicroRNA involvement in the pathogenesis and management of breast cancer
J. Clin. Pathol.,
May 1, 2009;
62(5):
422 - 428.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Moriyama, K. Ohuchida, K. Mizumoto, J. Yu, N. Sato, T. Nabae, S. Takahata, H. Toma, E. Nagai, and M. Tanaka
MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance
Mol. Cancer Ther.,
May 1, 2009;
8(5):
1067 - 1074.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Lebanony, H. Benjamin, S. Gilad, M. Ezagouri, A. Dov, K. Ashkenazi, N. Gefen, S. Izraeli, G. Rechavi, H. Pass, et al.
Diagnostic Assay Based on hsa-miR-205 Expression Distinguishes Squamous From Nonsquamous Non-Small-Cell Lung Carcinoma
J. Clin. Oncol.,
April 20, 2009;
27(12):
2030 - 2037.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. X. Lu, A. Munitz, and M. E. Rothenberg
MicroRNA-21 Is Up-Regulated in Allergic Airway Inflammation and Regulates IL-12p35 Expression
J. Immunol.,
April 15, 2009;
182(8):
4994 - 5002.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Avissar, B. C. Christensen, K. T. Kelsey, and C. J. Marsit
MicroRNA Expression Ratio Is Predictive of Head and Neck Squamous Cell Carcinoma
Clin. Cancer Res.,
April 15, 2009;
15(8):
2850 - 2855.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Hu, H. M. Stern, L. Ge, C. O'Brien, L. Haydu, C. D. Honchell, P. M. Haverty, B. A. Peters, T. D. Wu, L. C. Amler, et al.
Genetic Alterations and Oncogenic Pathways Associated with Breast Cancer Subtypes
Mol. Cancer Res.,
April 1, 2009;
7(4):
511 - 522.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. L. Bartels and G. J. Tsongalis
MicroRNAs: Novel Biomarkers for Human Cancer
Clin. Chem.,
April 1, 2009;
55(4):
623 - 631.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. V. Iorio, P. Casalini, C. Piovan, G. Di Leva, A. Merlo, T. Triulzi, S. Menard, C. M. Croce, and E. Tagliabue
microRNA-205 Regulates HER3 in Human Breast Cancer
Cancer Res.,
March 15, 2009;
69(6):
2195 - 2200.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Hiyoshi, H. Kamohara, R. Karashima, N. Sato, Y. Imamura, Y. Nagai, N. Yoshida, E. Toyama, N. Hayashi, M. Watanabe, et al.
MicroRNA-21 Regulates the Proliferation and Invasion in Esophageal Squamous Cell Carcinoma
Clin. Cancer Res.,
March 15, 2009;
15(6):
1915 - 1922.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Wu, S. Zhu, Y. Ding, W. T. Beck, and Y.-Y. Mo
MicroRNA-mediated Regulation of Ubc9 Expression in Cancer Cells
Clin. Cancer Res.,
March 1, 2009;
15(5):
1550 - 1557.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Divakaran and D. L. Mann
The Emerging Role of MicroRNAs in Cardiac Remodeling and Heart Failure
Circ. Res.,
November 7, 2008;
103(10):
1072 - 1083.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L.-X. Yan, X.-F. Huang, Q. Shao, M.-Y. Huang, L. Deng, Q.-L. Wu, Y.-X. Zeng, and J.-Y. Shao
MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis
RNA,
November 1, 2008;
14(11):
2348 - 2360.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Papagiannakopoulos, A. Shapiro, and K. S. Kosik
MicroRNA-21 Targets a Network of Key Tumor-Suppressive Pathways in Glioblastoma Cells
Cancer Res.,
October 1, 2008;
68(19):
8164 - 8172.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Markou, E. G. Tsaroucha, L. Kaklamanis, M. Fotinou, V. Georgoulias, and E. S. Lianidou
Prognostic Value of Mature MicroRNA-21 and MicroRNA-205 Overexpression in Non-Small Cell Lung Cancer by Quantitative Real-Time RT-PCR
Clin. Chem.,
October 1, 2008;
54(10):
1696 - 1704.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Gabriely, T. Wurdinger, S. Kesari, C. C. Esau, J. Burchard, P. S. Linsley, and A. M. Krichevsky
MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators
Mol. Cell. Biol.,
September 1, 2008;
28(17):
5369 - 5380.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-J. Hu, G. Ren, J.-L. Liu, Z.-A. Zhao, Y.-S. Yu, R.-W. Su, X.-H. Ma, H. Ni, W. Lei, and Z.-M. Yang
MicroRNA Expression and Regulation in Mouse Uterus during Embryo Implantation
J. Biol. Chem.,
August 22, 2008;
283(34):
23473 - 23484.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Sayed, S. Rane, J. Lypowy, M. He, I.-Y. Chen, H. Vashistha, L. Yan, A. Malhotra, D. Vatner, and M. Abdellatif
MicroRNA-21 Targets Sprouty2 and Promotes Cellular Outgrowths
Mol. Biol. Cell,
August 1, 2008;
19(8):
3272 - 3282.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Kida and Y.-P. Han
MicroRNA Expression in Colon Adenocarcinoma
JAMA,
June 11, 2008;
299(22):
2628 - 2628.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Hudder and R. F. Novak
miRNAs: Effectors of Environmental Influences on Gene Expression and Disease
Toxicol. Sci.,
June 1, 2008;
103(2):
228 - 240.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Jongen-Lavrencic, S. M. Sun, M. K. Dijkstra, P. J. M. Valk, and B. Lowenberg
MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia
Blood,
May 15, 2008;
111(10):
5078 - 5085.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. G. Romero, M. W. Plonczynski, C. A. Carvajal, E. P. Gomez-Sanchez, and C. E. Gomez-Sanchez
Microribonucleic Acid-21 Increases Aldosterone Secretion and Proliferation in H295R Human Adrenocortical Cells
Endocrinology,
May 1, 2008;
149(5):
2477 - 2483.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Ivanovska, A. S. Ball, R. L. Diaz, J. F. Magnus, M. Kibukawa, J. M. Schelter, S. V. Kobayashi, L. Lim, J. Burchard, A. L. Jackson, et al.
MicroRNAs in the miR-106b Family Regulate p21/CDKN1A and Promote Cell Cycle Progression
Mol. Cell. Biol.,
April 1, 2008;
28(7):
2167 - 2174.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Zhang
MicroRNomics: a newly emerging approach for disease biology
Physiol Genomics,
April 1, 2008;
33(2):
139 - 147.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. E. Callis, Z. Deng, J.-F. Chen, and D.-Z. Wang
Muscling Through the microRNA World
Experimental Biology and Medicine,
February 1, 2008;
233(2):
131 - 138.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Lakshmipathy and R. P. Hart
Concise Review: MicroRNA Expression in Multipotent Mesenchymal Stromal Cells
Stem Cells,
February 1, 2008;
26(2):
356 - 363.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Schetter, S. Y. Leung, J. J. Sohn, K. A. Zanetti, E. D. Bowman, N. Yanaihara, S. T. Yuen, T. L. Chan, D. L. W. Kwong, G. K. H. Au, et al.
MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon Adenocarcinoma
JAMA,
January 30, 2008;
299(4):
425 - 436.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. B. Frankel, N. R. Christoffersen, A. Jacobsen, M. Lindow, A. Krogh, and A. H. Lund
Programmed Cell Death 4 (PDCD4) Is an Important Functional Target of the MicroRNA miR-21 in Breast Cancer Cells
J. Biol. Chem.,
January 11, 2008;
283(2):
1026 - 1033.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. E. Blower, J.-H. Chung, J. S. Verducci, S. Lin, J.-K. Park, Z. Dai, C.-G. Liu, T. D. Schmittgen, W. C. Reinhold, C. M. Croce, et al.
MicroRNAs modulate the chemosensitivity of tumor cells
Mol. Cancer Ther.,
January 1, 2008;
7(1):
1 - 9.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-B. Shi, L. Xue, J. Yang, A.-H. Ma, J. Zhao, M. Xu, C. G. Tepper, C. P. Evans, H.-J. Kung, and R. W. deVere White
An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells
PNAS,
December 11, 2007;
104(50):
19983 - 19988.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. U. Mertens-Talcott, S. Chintharlapalli, X. Li, and S. Safe
The Oncogenic microRNA-27a Targets Genes That Regulate Specificity Protein Transcription Factors and the G2-M Checkpoint in MDA-MB-231 Breast Cancer Cells
Cancer Res.,
November 15, 2007;
67(22):
11001 - 11011.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. V. Iorio, R. Visone, G. Di Leva, V. Donati, F. Petrocca, P. Casalini, C. Taccioli, S. Volinia, C.-G. Liu, H. Alder, et al.
MicroRNA Signatures in Human Ovarian Cancer
Cancer Res.,
September 15, 2007;
67(18):
8699 - 8707.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Berkhout and K.-T. Jeang
RISCy Business: MicroRNAs, Pathogenesis, and Viruses
J. Biol. Chem.,
September 14, 2007;
282(37):
26641 - 26645.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Zhang, J. E. Dahlberg, and W. Tam
MicroRNAs in Tumorigenesis: A Primer
Am. J. Pathol.,
September 1, 2007;
171(3):
728 - 738.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Hurt and W. L. Farrar
The STATus of miR-21 in apoptosis
Blood,
August 15, 2007;
110(4):
1086 - 1087.
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|